Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children

Nutrition

Volumn 19, Issue 9, 2003, Pages 716-721

  Cruchet, Sylvia ^a   Obregon, Maria Clara ^a   Salazar, Gabriela ^a   Diaz, Eric ^a   Gotteland, Martin ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Children; Functional food; Helicobacter pylori; Lactobacillus johnsonii; Probiotic

Indexed keywords

CARBON 13; CARBON DIOXIDE; PROBIOTIC AGENT;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOOD COMPOSITION; FOOD INTAKE; HEAT TREATMENT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LACTIC ACID BACTERIUM; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI; MALE; MICROORGANISM; POPULATION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; SOCIAL STATUS; SOCIOECONOMICS; UREA BREATH TEST; VEGETABLE;

HELICOBACTER; HELICOBACTER PYLORI; LACTOBACILLUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI;

EID: 0043072977     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(03)00109-6     Document Type: Article

References (41)

1. Hart A.L., Stagg A.J., Frame M., et al. Review article the role of the gut flora in health and disease, and its modification as therapy . Aliment Pharmacol Ther. 16:2002;1383.
2. Salminen S., Arvilommi H. Probiotics demonstrating efficacy in clinical settings. Clin Infect Dis. 32:2001;1577.
3. Heyman M., Ménard S. Probiotic microorganisms how they affect intestinal pathophysiology . Cell Mol Life Sci. 59:2002;1151.
4. Riley M.A., Wertz J.E. Bacteriocins evolution, ecology, and application . Annu Rev Microbiol. 56:2002;117.
5. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 22:2002;283.
6. Bernet-Camard M.F., Lievin V., Brassart D., et al. The human Lactobacillus acidophilus strain La1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol. 63:1997;2747.
7. Hudault S., Liévin V., Bernet-Camard M.F., Servin A. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella thyphimurium C5 infection. Appl Environ Microbiol. 63:1997;513.
8. Coconnier MH, Lievin V, Hemery E, Servin A. Antagonistic activity against Helicobacter pylori in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998:4573.
9. Bhatia S.J., Kochar N., Abraham P., Nair N.G., Mehta A.P. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol. 27:1989;2328.
10. Marshall B. Helicobacter pylori. Am J Gastroenterol. 89:1994;116.
11. Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65.
12. Parsonnet J., Friedman G.D., Vandersteen D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma (see comments). N Engl J Med. 325:1991;1127.
13. Gold B.D. Helicobacter pylori infection in children. Curr Probl Pediatr. 31:2001;243.
14. Hopkins R.J., Vial P., Ferreccio C., et al. Seroprevalence of Helicobacter pylori in Chile vegetables may serve as one route of transmission . J Infect Dis. 168:1993;222.
15. Gold B.D., Coletti R.B., Abbott M., et al. Helicobacter pylori infection in children recommendations for diagnosis and treatment . J Pediatr Gastroenterol Nutr. 31:2000;490.
16. Sörberg M., Hanberger H., Nilsson M., Björkman A., Nilsson L. Risk of development of in vitro resistance to amoxicillin, clarithromycin and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother. 42:1998;1222.
17. Sivam G.P. Protection against Helicobacter pylori and other bacterial infections by garlic. J Nutr. 131:2001;1106S.
18. Daroch F., Hoeneisen M., Gonzalez C.L., et al. In vitro antibacterial activity of Chilean red wine against Helicobacter pylori. Microbios. 104:2001;79.
19. Alsahli M., Michetti P. Lactobacilli for the management of Helicobacter pylori. Nutrition. 17:2001;268.
20. Conway P.L., Gorbach S.L., Goldin B.R. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci. 70:1987;1.
21. Marteau P., Minekus M., Havenaar R., Huis In't Veld J.H.J. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine validation and the effects of bile . J Dairy Sci. 80:1997;1031.
22. Michetti P., Dorta G., Wiesel P.H., et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion. 60:1999;203.
23. Albala C., Vio F. Epidemiological transition in Latin America the case of Chile . Public Health. 109:1995;431.
24. Goodman K.J., Correa P. The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol. 24:1995;875.
25. 13C-urea breath test as a predictor of intragastric bacterial load and severity of Helicobacter pylori gastritis. Scand J Clin Lab Invest. 58:1998;19.
26. 13C-urea breath test. J Pediatr Gastroenterol Nutr. 25:1997;84.
27. 13C-urea breath test rest to quantify H. pylori colonization of gastric mucosa and association with severity of inflammation. Gastroenterology. 106:1994;A48.
28. 13C-urea breath test. Gastroenterology. 106:1994;A93.
29. 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Correlation to histology, origin of "false" results, and influence of food intake. Scand J Gastroenterol. 32:1997;308.
30. Sakamoto I., Igarashi M., Kimura K., et al. Suppressive effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother. 47:2001;709.
31. Gotteland M., Corvalan A., Sarmiento F., et al. Gastric permeability is not increased in children colonized by cagA-positive or cagA-negative strains of Helicobacter pylori. Dig Liver Dis. 33:2001;750.
32. Llorens P. Gastric cancer in Chile. Gastrointest Endosc. 49:1999;408.
33. Gotteland M., Cruchet S., Verbeke S. Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Alim Pharmacol Ther. 15:2001;11.
34. Elliott S.N., Buret A., McKnight W., Miller M.J.S., Wallace J.L. Bacteria rapidly colonize and modulate healing of gastric ulcers in rats. Am J Physiol. 38:1998;G425.
35. Mukai T., Asasaka T., Sato E., et al. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol. 32:2002;105.
36. Kabir A.M.A., Aiba Y., Takagi A., et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut. 41:1997;49.
37. Aiba Y., Suzuki N., Kabir A.M., Takagi A., Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol. 93:1998;2097.
38. Von der weid T., Bulliard C., Schiffrin E. Induction by lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol. 4:2001;695.
39. Felley C.P., Corthésy-Theulaz I., Blanco-Rivero J.L., et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol. 13:2001;25.
40. Canducci F., Armuzzi A., Cremonini F., et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther. 14:2000;1625.
41. Armuzzi A., Cremonini F., Bartolozzi F., et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 15:2001;163.